Home > Boards > US Listed > Medical - Drugs >

MEI Pharma, Inc. (MEIP)

MEIP RSS Feed
Add MEIP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/17/2020 12:33:43 PM - Followers: 90 - Board type: Free - Posts Today: 0


MEI Pharma (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. Our portfolio of drug candidates includes Pracinostat, an oral HDAC inhibitor being developed in combination with azacitidine for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Our clinical development pipeline also includes ME-401, a highly selective oral PI3K delta inhibitor, and ME-344, a novel mitochondrial inhibitor.

http://www.meipharma.com/our-programs/pracinostat

In August 2016, we announced that the U.S. Food & Drug Administration granted Breakthrough Therapy Designation for Pracinostat in combination with azacitidine for the treatment of patients with newly diagnosed AML who are ≥75 years of age or unfit for intensive chemotherapy. Later that month, we entered into an exclusive licensing, development and commercialization agreement with Helsinn Healthcare, SA, a Swiss pharmaceutical corporation, for Pracinostat in AML and other potential indications, including MDS.

http://www.meipharma.com/our-programs/me-401

ME-401 is a potent and selective oral inhibitor of PI3K delta, a molecular target that plays a critical role in the proliferation and survival of certain hematologic cancer cells. Results from a first-in-human, single ascending dose clinical study suggest that ME-401 has the potential for an improved therapeutic window compared to other PI3K delta inhibitors, with a half-life that supports once-daily dosing. A Phase Ib dose-escalation study of ME-401 in patients with recurrent chronic lymphocytic leukemia (CLL) or follicular non-Hodgkin's lymphoma (fNHL) opened for enrollment in September 2016.

http://www.meipharma.com/our-programs/me-344

ME-344 is our isoflavone-derived mitochondrial inhibitor drug candidate. Results from a Phase I clinical study of ME-344 in patients with refractory solid tumors showed evidence of clinical activity, including a confirmed partial response in a heavily pre-treated patient with small cell lung cancer who remained on study for two years. An investigator-sponsored study of ME-344 in combination with the VEGF inhibitor bevacizumab (marketed as Avastin®) in HER2-negative breast cancer opened for enrollment in August 2016.

MEI Pharma is listed on the Nasdaq Capital Market (Nasdaq: MEIP).

Financial Highlights as of September 30, 2016
- $58.9 million in cash
- No debt
- 36.8 million shares outstanding

Company website:
http://www.meipharma.com

Company presentation:
http://www.meipharma.com/sites/default/files/meip_presentation_-_stifel_nov_2016_-_final_2_0.pdf

MEIP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MEIP News: MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing 09/15/2020 08:00:00 AM
MEIP News: MEI Pharma Reports Fiscal Year 2020 Results and Operational Highlights 09/09/2020 04:05:00 PM
MEIP News: Annual Report (10-k) 09/09/2020 04:02:58 PM
MEIP News: MEI Pharma to Present at Upcoming Investor Conferences in September 09/04/2020 08:00:00 AM
MEIP News: MEI Pharma to Release 2020 Fiscal Year End Financial Results and Provide Corporate Update on September 9, 2020 09/02/2020 08:00:00 AM
PostSubject
#1347   Tipranks added them as one of their top doczaius 08/17/20 12:33:43 PM
#1346   I am continuing to buy at these prices. Aarin 07/29/20 10:24:01 AM
#1345   Back in at $3.02. I have a Aarin 07/23/20 04:02:33 PM
#1344   This is a pretty big deal for me. Aarin 07/02/20 11:10:30 AM
#1343   MEIP & partner Helsinn announce discontinuation of Phase bladerunner1717 07/02/20 10:00:56 AM
#1342   WATCH for possible breakout above 4.36, no resistance realfast95 06/23/20 02:12:28 PM
#1341   something is brewing, large blocks today realfast95 06/22/20 03:47:05 PM
#1340   MEIP presents data at ASCO on its FOURTH bladerunner1717 06/01/20 06:59:49 PM
#1339   MEIP crashes through its 52-week high today. Holding bladerunner1717 06/01/20 04:03:32 PM
#1338   SunTrust's analysis of MEIP bladerunner1717 05/30/20 08:13:12 PM
#1337   Friday's price in a new YEALY (+10 days) Aarin 05/30/20 09:22:57 AM
#1336   This is great news! I still believe Aarin 05/30/20 09:19:55 AM
#1335   SunTrust Robinson Humphrey initiates coverage of MEIP with bladerunner1717 05/29/20 01:48:06 PM
#1334   Lurkers! Get in now! Aarin 05/24/20 06:59:06 AM
#1333   Helsinn, MEIP's partner, reports updated Phase II data bladerunner1717 05/13/20 11:40:38 PM
#1332   I love me MEIP. I underwater right now Bean Bag 05/04/20 04:23:01 PM
#1331   Bullish article on MEIP (from "Seeking Alpha") bladerunner1717 04/27/20 01:40:42 PM
#1330   What is your price target then? Just wonder. andrewflying 04/17/20 01:45:19 PM
#1329   agree 100% with you edwardport 04/16/20 07:11:19 PM
#1328   MEIP traded over 100X its average volume. bladerunner1717 04/14/20 04:43:03 PM
#1327   * * $MEIP Video Chart 04-14-2020 * * ClayTrader 04/14/20 04:36:26 PM
#1326   $MEIP: it has no business trading under $7 right now. Hercules1 04/14/20 01:03:32 PM
#1325   YES, COULD HIT $3 AND THEN $4 REAL QUICK edwardport 04/14/20 09:56:27 AM
#1324   I like it !!! I’ll add more if eur06 04/14/20 09:33:27 AM
#1323   MEIP will run to 5-6 dollars. dinogreeves 04/14/20 07:32:46 AM
#1322   Insider buys at MEIP bladerunner1717 12/30/19 11:05:11 AM
#1321   "Seeking Alpha" on MEIP bladerunner1717 12/27/19 05:15:10 PM
#1320   MEIP closes public offering. MEIP now has a bladerunner1717 12/19/19 01:08:20 PM
#1319   * * $MEIP Video Chart 12-17-2019 * * ClayTrader 12/17/19 06:03:34 PM
#1318   News: $MEIP MEI Pharma Announces Pricing of Public whytestocks 12/17/19 08:15:19 AM
#1317   News: $MEIP MEI Pharma Announces Proposed Public Offering whytestocks 12/16/19 04:30:20 PM
#1316   MEIP (finally) breaks thru 200-day moving average ($2.00). bladerunner1717 12/04/19 02:52:17 PM
#1315   Institutional investors sold almost 7 million shares last bladerunner1717 11/15/19 12:35:53 PM
#1314   MEIP Chart conix 10/04/19 08:28:22 AM
#1313   News: $MEIP MEI Pharma to Present at the whytestocks 08/29/19 08:20:24 AM
#1312   MEIP Investment Highlights: conix 08/19/19 09:57:19 AM
#1311   MEI Pharma: Time To Reload At Key Support stockguard 06/16/19 03:18:40 PM
#1310   The 7 analysts offering 12-month price forecasts for stockguard 06/14/19 04:48:54 PM
#1309   MEIP ME-401 data at ASCO bladerunner1717 06/03/19 11:25:48 AM
#1308   MEIP ME-344 at ASCO bladerunner1717 06/02/19 07:54:48 PM
#1307   Joseph Edelman's PERCEPTIVE ADVISORS likes MEIP bladerunner1717 04/15/19 10:10:50 AM
#1306   MEIP at Oppenheimer. bladerunner1717 03/21/19 07:46:41 PM
#1305   Updated Price Target by Analyst Oppenheimer. $7 staticmirror79 02/27/19 04:35:30 PM
#1304   re: MEIP bladerunner1717 02/15/19 10:02:42 AM
#1303   MEIP reports 2nd quarter fiscal year results bladerunner1717 02/08/19 02:05:23 PM
#1302   H.C. Wainwright initiates MEIP with a "buy." bladerunner1717 12/21/18 05:58:36 PM
#1301   Day 2 of MEI conference data: MEI Pharma Presents ChrisInSF 12/02/18 12:33:35 PM
#1300   First of three days of data. Below is cut ChrisInSF 12/01/18 09:11:16 PM
#1299   MEIP reports 1st quarter, 2019 (Fiscal) results. Close bladerunner1717 11/09/18 12:25:13 PM
#1298   MEIP gets a partner for ME-401 in Japan bladerunner1717 11/05/18 09:33:07 AM
PostSubject
Consent Preferences